An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey
Sponsor: Centre Hospitalier Universitaire de Nīmes
Listed as NCT02850029, this observational or N/A phase trial focuses on Critical Illness and Underdosing of Aminoglycosides and remains completed. Sponsored by Centre Hospitalier Universitaire de Nīmes, it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Dec 2025 — Present [monthly]
Completed
-
Sep 2025 — Dec 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
▶ Show 6 earlier versions
-
Feb 2019 — Jan 2021 [monthly]
Completed
-
Aug 2018 — Feb 2019 [monthly]
Completed
Status: Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aix-en-Provence, France , Alès, France , Amiens, France , Angers, France , Arles, France , Athens, Greece , Aulnay-sous-Bois, France , Aurillac, France , Avignon, France , Besançon, France and 53 more locations